Dunston Almeida is the founder and Chief Executive Officer of triValence. Dunston has over 20 years of experience in tech and healthcare investing at leading global corporations. Previously, he was part of the executive team that grew eviCore from a few hundred million to $3.6 billion leading to its eventual sale to Express Scripts, the largest stand-alone PBM. He also headed up Medco’s (Express Scripts) Emerging Markets strategies, including Brazil, India and China. He has worked on transactions across the healthcare spectrum, including HCIT, CROs, home infusion, specialty pharma, Medicare/Medicaid and has completed over $30 billion of M&A in North America, Europe, Latin America and Asia with extensive experience across the entire capital structure.

He graduated from Cornell University with a degree in Electrical Engineering.